Gene Symbol | Gene ID | Gene Info |
---|---|---|
Wrnip1
|
ENSMUSG00000021400.6 | Werner helicase interacting protein 1 |
Mta3
|
ENSMUSG00000055817.11 | metastasis associated 3 |
Rcor1
|
ENSMUSG00000037896.11 | REST corepressor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_83705408_83705686 | Mta3 | 616 | 0.795708 | 0.94 | 4.9e-03 | Click! |
chr17_83706385_83706725 | Mta3 | 364 | 0.905607 | 0.76 | 8.2e-02 | Click! |
chr17_83732249_83732426 | Mta3 | 3173 | 0.312983 | 0.71 | 1.2e-01 | Click! |
chr17_83705709_83705883 | Mta3 | 367 | 0.904412 | 0.60 | 2.1e-01 | Click! |
chr17_83734588_83734739 | Mta3 | 5499 | 0.263734 | 0.59 | 2.2e-01 | Click! |
chr12_111037215_111037375 | Rcor1 | 2056 | 0.222355 | 0.92 | 8.5e-03 | Click! |
chr12_111037417_111037648 | Rcor1 | 1819 | 0.246272 | 0.92 | 8.5e-03 | Click! |
chr12_111051690_111051903 | Rcor1 | 11998 | 0.123971 | 0.91 | 1.2e-02 | Click! |
chr12_111050226_111050608 | Rcor1 | 10619 | 0.125894 | -0.82 | 4.4e-02 | Click! |
chr12_111039297_111039503 | Rcor1 | 49 | 0.962093 | 0.81 | 5.0e-02 | Click! |
chr13_32802244_32802687 | Wrnip1 | 349 | 0.494080 | 0.98 | 8.3e-04 | Click! |
chr13_32828037_32828211 | Wrnip1 | 7358 | 0.139030 | 0.97 | 9.4e-04 | Click! |
chr13_32795278_32795444 | Wrnip1 | 6677 | 0.142649 | 0.93 | 7.4e-03 | Click! |
chr13_32828221_32828372 | Wrnip1 | 7530 | 0.138472 | 0.90 | 1.5e-02 | Click! |
chr13_32819369_32819548 | Wrnip1 | 1308 | 0.354438 | 0.86 | 2.7e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_28886991_28887442 | 7.60 |
Gm48080 |
predicted gene, 48080 |
834 |
0.6 |
chr19_46141233_46141384 | 7.45 |
Pitx3 |
paired-like homeodomain transcription factor 3 |
325 |
0.82 |
chr15_100632605_100632917 | 6.89 |
Smagp |
small cell adhesion glycoprotein |
2739 |
0.12 |
chr8_119416779_119416930 | 6.04 |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
17270 |
0.13 |
chr8_119417171_119417322 | 5.20 |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
16878 |
0.13 |
chr11_75430733_75430997 | 5.17 |
Gm12337 |
predicted gene 12337 |
3112 |
0.11 |
chr8_119417331_119417482 | 4.59 |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
16718 |
0.14 |
chr15_31117311_31117579 | 4.46 |
Gm26416 |
predicted gene, 26416 |
76893 |
0.08 |
chr1_39192284_39192607 | 4.39 |
Npas2 |
neuronal PAS domain protein 2 |
1286 |
0.45 |
chr12_28898892_28899474 | 4.11 |
Gm31508 |
predicted gene, 31508 |
11046 |
0.17 |
chr19_46142576_46142826 | 4.07 |
Pitx3 |
paired-like homeodomain transcription factor 3 |
1718 |
0.25 |
chr9_65334133_65334359 | 4.04 |
Gm39363 |
predicted gene, 39363 |
1726 |
0.18 |
chr7_112184980_112185156 | 3.97 |
Dkk3 |
dickkopf WNT signaling pathway inhibitor 3 |
26011 |
0.21 |
chr19_46140028_46140457 | 3.93 |
Pitx3 |
paired-like homeodomain transcription factor 3 |
741 |
0.53 |
chr10_117025914_117026071 | 3.66 |
Gm10747 |
predicted gene 10747 |
17754 |
0.11 |
chr8_10899350_10899661 | 3.53 |
4833411C07Rik |
RIKEN cDNA 4833411C07 gene |
417 |
0.64 |
chr5_33218123_33218481 | 3.48 |
Spon2 |
spondin 2, extracellular matrix protein |
107 |
0.96 |
chr10_22362892_22363057 | 3.47 |
Raet1d |
retinoic acid early transcript delta |
1080 |
0.42 |
chrX_36329380_36329669 | 3.43 |
Lonrf3 |
LON peptidase N-terminal domain and ring finger 3 |
308 |
0.87 |
chr1_132587567_132587718 | 3.42 |
Nfasc |
neurofascin |
502 |
0.8 |
chr15_99093772_99093973 | 3.37 |
Dnajc22 |
DnaJ heat shock protein family (Hsp40) member C22 |
702 |
0.47 |
chr19_42602482_42602861 | 3.35 |
Loxl4 |
lysyl oxidase-like 4 |
650 |
0.71 |
chr8_119447272_119447614 | 3.27 |
Necab2 |
N-terminal EF-hand calcium binding protein 2 |
724 |
0.61 |
chr19_4024247_4024692 | 3.27 |
Gstp1 |
glutathione S-transferase, pi 1 |
11524 |
0.06 |
chr3_104540522_104540806 | 3.16 |
Lrig2 |
leucine-rich repeats and immunoglobulin-like domains 2 |
28746 |
0.1 |
chr9_63555594_63556179 | 3.15 |
Gm16759 |
predicted gene, 16759 |
24534 |
0.17 |
chr7_127803770_127804052 | 3.14 |
9430064I24Rik |
RIKEN cDNA 9430064I24 gene |
1149 |
0.22 |
chr18_10934499_10934650 | 3.14 |
Gm7575 |
predicted gene 7575 |
5690 |
0.24 |
chr4_132974013_132974164 | 3.13 |
Fgr |
FGR proto-oncogene, Src family tyrosine kinase |
7 |
0.97 |
chr4_133753668_133753824 | 3.11 |
Arid1a |
AT rich interactive domain 1A (SWI-like) |
135 |
0.95 |
chr19_46133855_46134398 | 3.10 |
Elovl3 |
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 3 |
2229 |
0.19 |
chr19_46137654_46137874 | 3.08 |
Pitx3 |
paired-like homeodomain transcription factor 3 |
475 |
0.71 |
chr10_22361736_22361909 | 3.04 |
Raet1d |
retinoic acid early transcript delta |
72 |
0.96 |
chr12_111454995_111455516 | 3.03 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
4736 |
0.13 |
chr18_20938674_20939098 | 3.03 |
Rnf125 |
ring finger protein 125 |
5739 |
0.23 |
chr13_93627456_93627944 | 3.01 |
Gm15622 |
predicted gene 15622 |
2318 |
0.25 |
chr11_3983568_3983719 | 2.98 |
Gal3st1 |
galactose-3-O-sulfotransferase 1 |
7 |
0.95 |
chr1_39186773_39187108 | 2.95 |
Mir6349 |
microRNA 6349 |
52 |
0.98 |
chr5_118294350_118294584 | 2.92 |
Gm25076 |
predicted gene, 25076 |
28018 |
0.15 |
chr11_101668758_101669043 | 2.88 |
Arl4d |
ADP-ribosylation factor-like 4D |
3359 |
0.12 |
chr17_28279592_28279743 | 2.86 |
Ppard |
peroxisome proliferator activator receptor delta |
7548 |
0.11 |
chr6_121890040_121890777 | 2.86 |
Mug1 |
murinoglobulin 1 |
4831 |
0.21 |
chr14_30919586_30919927 | 2.84 |
Itih3 |
inter-alpha trypsin inhibitor, heavy chain 3 |
3793 |
0.13 |
chr9_115456234_115456417 | 2.83 |
Gm5921 |
predicted gene 5921 |
17744 |
0.16 |
chr7_30361694_30362080 | 2.79 |
Lrfn3 |
leucine rich repeat and fibronectin type III domain containing 3 |
885 |
0.31 |
chr19_46136477_46136807 | 2.74 |
Pitx3 |
paired-like homeodomain transcription factor 3 |
647 |
0.58 |
chr18_20986270_20986434 | 2.74 |
Rnf138 |
ring finger protein 138 |
14989 |
0.19 |
chr19_4441062_4441213 | 2.69 |
A930001C03Rik |
RIKEN cDNA A930001C03 gene |
1578 |
0.23 |
chr15_100633031_100633289 | 2.68 |
Smagp |
small cell adhesion glycoprotein |
2340 |
0.14 |
chr8_94172420_94173095 | 2.66 |
Mt2 |
metallothionein 2 |
93 |
0.88 |
chr2_25628694_25629041 | 2.65 |
Fcna |
ficolin A |
837 |
0.28 |
chr8_119417830_119417981 | 2.63 |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
16219 |
0.14 |
chr19_7160219_7160696 | 2.63 |
Otub1 |
OTU domain, ubiquitin aldehyde binding 1 |
40007 |
0.09 |
chr10_117025635_117025807 | 2.60 |
Gm10747 |
predicted gene 10747 |
18025 |
0.11 |
chr10_22173370_22173547 | 2.59 |
Raet1e |
retinoic acid early transcript 1E |
63 |
0.95 |
chr8_119417985_119418136 | 2.59 |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
16064 |
0.14 |
chr1_156660314_156660660 | 2.58 |
Tor3a |
torsin family 3, member A |
2029 |
0.27 |
chr17_31874093_31874279 | 2.57 |
Sik1 |
salt inducible kinase 1 |
18382 |
0.13 |
chr15_99717976_99718517 | 2.55 |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 (soluble) |
667 |
0.44 |
chr6_94813223_94813696 | 2.54 |
Gm7833 |
predicted gene 7833 |
7071 |
0.15 |
chr13_78199479_78199630 | 2.51 |
A830082K12Rik |
RIKEN cDNA A830082K12 gene |
184 |
0.51 |
chr10_75044109_75044374 | 2.51 |
Rab36 |
RAB36, member RAS oncogene family |
6018 |
0.16 |
chr11_101377034_101377689 | 2.50 |
G6pc |
glucose-6-phosphatase, catalytic |
9800 |
0.06 |
chr3_83015139_83015590 | 2.49 |
Gm30097 |
predicted gene, 30097 |
6876 |
0.14 |
chr7_44810745_44811033 | 2.47 |
Atf5 |
activating transcription factor 5 |
4769 |
0.08 |
chr1_74343162_74343341 | 2.45 |
Pnkd |
paroxysmal nonkinesiogenic dyskinesia |
10588 |
0.09 |
chr10_8095747_8095932 | 2.45 |
Gm48614 |
predicted gene, 48614 |
74547 |
0.1 |
chr10_41677490_41677641 | 2.45 |
Mir3473b |
microRNA 3473b |
6826 |
0.15 |
chr7_73574787_73575110 | 2.44 |
1810026B05Rik |
RIKEN cDNA 1810026B05 gene |
16553 |
0.1 |
chr1_72833162_72833313 | 2.43 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
7915 |
0.22 |
chr7_127804168_127804541 | 2.43 |
9430064I24Rik |
RIKEN cDNA 9430064I24 gene |
1592 |
0.16 |
chr12_21134243_21134639 | 2.42 |
Asap2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
22487 |
0.19 |
chr12_21145146_21145377 | 2.41 |
Asap2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
33307 |
0.16 |
chr1_180166366_180166775 | 2.40 |
Cdc42bpa |
CDC42 binding protein kinase alpha |
5563 |
0.16 |
chr11_7203035_7203187 | 2.40 |
Igfbp1 |
insulin-like growth factor binding protein 1 |
5329 |
0.19 |
chr16_94290453_94290754 | 2.38 |
Hlcs |
holocarboxylase synthetase (biotin- [propriony-Coenzyme A-carboxylase (ATP-hydrolysing)] ligase) |
317 |
0.87 |
chr10_28094796_28094968 | 2.38 |
Ptprk |
protein tyrosine phosphatase, receptor type, K |
19872 |
0.21 |
chr10_80818693_80818857 | 2.38 |
Jsrp1 |
junctional sarcoplasmic reticulum protein 1 |
5277 |
0.08 |
chr19_46140539_46140690 | 2.37 |
Pitx3 |
paired-like homeodomain transcription factor 3 |
369 |
0.79 |
chr17_31871058_31871230 | 2.35 |
Sik1 |
salt inducible kinase 1 |
15340 |
0.14 |
chr5_115475861_115476388 | 2.35 |
Sirt4 |
sirtuin 4 |
3814 |
0.1 |
chr19_47279393_47279569 | 2.35 |
Mir6995 |
microRNA 6995 |
5892 |
0.15 |
chr9_110688995_110689492 | 2.35 |
Gm35715 |
predicted gene, 35715 |
14289 |
0.1 |
chr17_86946145_86946317 | 2.35 |
Atp6v1e2 |
ATPase, H+ transporting, lysosomal V1 subunit E2 |
1640 |
0.27 |
chr17_47059720_47059925 | 2.34 |
Gm4945 |
predicted gene 4945 |
16783 |
0.17 |
chr11_77901810_77902217 | 2.33 |
Pipox |
pipecolic acid oxidase |
7917 |
0.14 |
chr12_111454567_111454858 | 2.33 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
4193 |
0.14 |
chr11_95824766_95825172 | 2.32 |
Phospho1 |
phosphatase, orphan 1 |
469 |
0.69 |
chr18_20945707_20945922 | 2.30 |
Rnf125 |
ring finger protein 125 |
1189 |
0.52 |
chr10_8086797_8087175 | 2.28 |
Gm48614 |
predicted gene, 48614 |
65694 |
0.11 |
chr17_84896257_84896408 | 2.26 |
Gm49982 |
predicted gene, 49982 |
6237 |
0.19 |
chr15_36472369_36472551 | 2.26 |
Ankrd46 |
ankyrin repeat domain 46 |
24255 |
0.12 |
chr17_17826628_17827083 | 2.25 |
Spaca6 |
sperm acrosome associated 6 |
303 |
0.79 |
chr1_72180255_72180531 | 2.23 |
Mreg |
melanoregulin |
31914 |
0.12 |
chr6_121881536_121882068 | 2.23 |
Mug1 |
murinoglobulin 1 |
3775 |
0.23 |
chr8_12719084_12719404 | 2.23 |
Gm15348 |
predicted gene 15348 |
117 |
0.96 |
chr19_3850170_3850502 | 2.21 |
Chka |
choline kinase alpha |
1437 |
0.22 |
chr11_3984447_3984636 | 2.20 |
Gal3st1 |
galactose-3-O-sulfotransferase 1 |
828 |
0.43 |
chr13_51847050_51847248 | 2.19 |
Gadd45g |
growth arrest and DNA-damage-inducible 45 gamma |
405 |
0.88 |
chr13_40971914_40972082 | 2.19 |
Gcnt2 |
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme |
18583 |
0.1 |
chr6_72571943_72572128 | 2.19 |
Capg |
capping protein (actin filament), gelsolin-like |
16056 |
0.09 |
chr1_72827270_72827421 | 2.18 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
2023 |
0.37 |
chr8_126833044_126833199 | 2.18 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
6112 |
0.23 |
chr6_122339632_122339783 | 2.17 |
Phc1 |
polyhomeotic 1 |
1 |
0.97 |
chr5_114560586_114560754 | 2.17 |
Fam222a |
family with sequence similarity 222, member A |
7346 |
0.16 |
chr4_120067294_120067548 | 2.17 |
AL607142.1 |
novel protein |
2425 |
0.34 |
chr10_127614613_127614967 | 2.17 |
Lrp1 |
low density lipoprotein receptor-related protein 1 |
6132 |
0.1 |
chr6_72606365_72606640 | 2.17 |
Retsat |
retinol saturase (all trans retinol 13,14 reductase) |
143 |
0.87 |
chr11_4883931_4884115 | 2.17 |
Nipsnap1 |
nipsnap homolog 1 |
759 |
0.54 |
chr15_102179732_102179923 | 2.16 |
Csad |
cysteine sulfinic acid decarboxylase |
34 |
0.95 |
chr13_93626359_93626522 | 2.16 |
Gm15622 |
predicted gene 15622 |
1058 |
0.47 |
chr2_6057072_6057245 | 2.15 |
Upf2 |
UPF2 regulator of nonsense transcripts homolog (yeast) |
6731 |
0.22 |
chr1_165617606_165617906 | 2.15 |
Mpzl1 |
myelin protein zero-like 1 |
3777 |
0.14 |
chr12_21135593_21135759 | 2.14 |
Asap2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
23722 |
0.18 |
chr7_113228562_113228716 | 2.13 |
Arntl |
aryl hydrocarbon receptor nuclear translocator-like |
5984 |
0.23 |
chr1_185454772_185454950 | 2.13 |
Slc30a10 |
solute carrier family 30, member 10 |
13 |
0.93 |
chr7_113242228_113242404 | 2.12 |
Arntl |
aryl hydrocarbon receptor nuclear translocator-like |
2562 |
0.3 |
chr4_148040297_148040490 | 2.12 |
Mthfr |
methylenetetrahydrofolate reductase |
417 |
0.66 |
chr19_46137276_46137451 | 2.11 |
Pitx3 |
paired-like homeodomain transcription factor 3 |
74 |
0.95 |
chr19_42612050_42612489 | 2.11 |
Loxl4 |
lysyl oxidase-like 4 |
503 |
0.8 |
chr19_46132112_46132476 | 2.10 |
Elovl3 |
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 3 |
397 |
0.76 |
chr1_93145237_93145388 | 2.09 |
Agxt |
alanine-glyoxylate aminotransferase |
5433 |
0.14 |
chr17_50509012_50509163 | 2.09 |
Plcl2 |
phospholipase C-like 2 |
316 |
0.94 |
chr8_123978504_123978907 | 2.08 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
4417 |
0.12 |
chr15_85969731_85970002 | 2.07 |
Celsr1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
8864 |
0.21 |
chr19_3686522_3686708 | 2.06 |
Lrp5 |
low density lipoprotein receptor-related protein 5 |
51 |
0.96 |
chr17_29056624_29056784 | 2.06 |
Gm41556 |
predicted gene, 41556 |
156 |
0.9 |
chr7_30361407_30361626 | 2.06 |
Lrfn3 |
leucine rich repeat and fibronectin type III domain containing 3 |
1256 |
0.21 |
chr18_20989164_20989323 | 2.06 |
Rnf138 |
ring finger protein 138 |
12098 |
0.2 |
chr7_30353715_30354115 | 2.06 |
4930479H17Rik |
RIKEN cDNA 4930479H17 gene |
594 |
0.46 |
chr13_111809159_111809796 | 2.06 |
Gm15327 |
predicted gene 15327 |
336 |
0.59 |
chr5_8961694_8961940 | 2.05 |
Abcb4 |
ATP-binding cassette, sub-family B (MDR/TAP), member 4 |
3265 |
0.17 |
chr5_122284523_122284674 | 2.04 |
Pptc7 |
PTC7 protein phosphatase homolog |
233 |
0.88 |
chr1_182585215_182585532 | 2.04 |
Capn8 |
calpain 8 |
20335 |
0.16 |
chr17_33776838_33777473 | 2.03 |
Angptl4 |
angiopoietin-like 4 |
1310 |
0.23 |
chr9_57283258_57283868 | 2.03 |
1700017B05Rik |
RIKEN cDNA 1700017B05 gene |
20951 |
0.14 |
chr6_72619520_72620123 | 2.03 |
Tgoln1 |
trans-golgi network protein |
2821 |
0.11 |
chr12_21226918_21227272 | 2.02 |
AC156032.1 |
|
20228 |
0.14 |
chr7_35185152_35185303 | 2.01 |
Slc7a10 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 10 |
1158 |
0.36 |
chr1_180163928_180164201 | 2.00 |
Cdc42bpa |
CDC42 binding protein kinase alpha |
3057 |
0.2 |
chr1_184873599_184874011 | 1.99 |
C130074G19Rik |
RIKEN cDNA C130074G19 gene |
9413 |
0.16 |
chr2_32150767_32151076 | 1.99 |
Prrc2b |
proline-rich coiled-coil 2B |
161 |
0.93 |
chr10_63373272_63373423 | 1.99 |
Sirt1 |
sirtuin 1 |
8357 |
0.13 |
chr7_19816327_19816902 | 1.99 |
Gm16174 |
predicted gene 16174 |
61 |
0.88 |
chr11_98457765_98457940 | 1.99 |
Grb7 |
growth factor receptor bound protein 7 |
4063 |
0.1 |
chr19_42601924_42602199 | 1.99 |
Loxl4 |
lysyl oxidase-like 4 |
1260 |
0.45 |
chr14_30912992_30913256 | 1.98 |
Itih3 |
inter-alpha trypsin inhibitor, heavy chain 3 |
1005 |
0.39 |
chr7_3217705_3217856 | 1.98 |
Mir290a |
microRNA 290a |
846 |
0.18 |
chr11_75172316_75172519 | 1.97 |
1700016P03Rik |
RIKEN cDNA 1700016P03 gene |
143 |
0.85 |
chr8_119439834_119440348 | 1.97 |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
2902 |
0.2 |
chr7_113210463_113210620 | 1.97 |
Arntl |
aryl hydrocarbon receptor nuclear translocator-like |
2984 |
0.29 |
chr10_59943011_59943708 | 1.97 |
Ddit4 |
DNA-damage-inducible transcript 4 |
8475 |
0.18 |
chr18_7609653_7609809 | 1.96 |
Mpp7 |
membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7) |
749 |
0.7 |
chr14_25377112_25377271 | 1.95 |
Gm26660 |
predicted gene, 26660 |
1444 |
0.44 |
chr5_88952248_88952404 | 1.94 |
Slc4a4 |
solute carrier family 4 (anion exchanger), member 4 |
17754 |
0.25 |
chr18_75820116_75820288 | 1.94 |
Zbtb7c |
zinc finger and BTB domain containing 7C |
13 |
0.98 |
chr13_93627953_93628190 | 1.93 |
Gm15622 |
predicted gene 15622 |
2689 |
0.23 |
chr13_98694658_98695181 | 1.92 |
Tmem171 |
transmembrane protein 171 |
85 |
0.96 |
chr4_135957998_135958360 | 1.92 |
Hmgcl |
3-hydroxy-3-methylglutaryl-Coenzyme A lyase |
1548 |
0.21 |
chr9_123925739_123926174 | 1.92 |
Ccr1 |
chemokine (C-C motif) receptor 1 |
42736 |
0.1 |
chr12_80130651_80130980 | 1.91 |
2310015A10Rik |
RIKEN cDNA 2310015A10 gene |
1781 |
0.25 |
chr6_54719950_54720402 | 1.91 |
Gm44008 |
predicted gene, 44008 |
26530 |
0.15 |
chr6_72634309_72634791 | 1.91 |
Gm15401 |
predicted gene 15401 |
1703 |
0.17 |
chr11_7184254_7184557 | 1.91 |
Ccdc201 |
coiled coil domain 201 |
4164 |
0.2 |
chr6_72233913_72234064 | 1.91 |
Atoh8 |
atonal bHLH transcription factor 8 |
549 |
0.74 |
chr2_154590499_154590657 | 1.90 |
Pxmp4 |
peroxisomal membrane protein 4 |
13110 |
0.1 |
chr4_150030737_150031184 | 1.90 |
Gm13067 |
predicted gene 13067 |
18053 |
0.12 |
chr3_83043842_83044694 | 1.89 |
Fgb |
fibrinogen beta chain |
5595 |
0.15 |
chr2_32681906_32682535 | 1.89 |
Fpgs |
folylpolyglutamyl synthetase |
2784 |
0.1 |
chr12_85471975_85472347 | 1.89 |
Fos |
FBJ osteosarcoma oncogene |
1729 |
0.32 |
chr11_97706170_97706325 | 1.89 |
Psmb3 |
proteasome (prosome, macropain) subunit, beta type 3 |
2813 |
0.1 |
chr11_110032912_110033079 | 1.88 |
Abca8a |
ATP-binding cassette, sub-family A (ABC1), member 8a |
2914 |
0.31 |
chr3_104541230_104541625 | 1.88 |
Lrig2 |
leucine-rich repeats and immunoglobulin-like domains 2 |
29509 |
0.1 |
chr1_93145993_93146195 | 1.88 |
Agxt |
alanine-glyoxylate aminotransferase |
6215 |
0.13 |
chr16_30258016_30258167 | 1.88 |
Gm49645 |
predicted gene, 49645 |
2939 |
0.19 |
chr3_67263308_67263719 | 1.88 |
Mlf1 |
myeloid leukemia factor 1 |
110584 |
0.06 |
chr11_86971305_86971591 | 1.87 |
Ypel2 |
yippee like 2 |
576 |
0.75 |
chr7_46839028_46839384 | 1.86 |
Ldha |
lactate dehydrogenase A |
2269 |
0.15 |
chr10_8195524_8195685 | 1.86 |
Gm30906 |
predicted gene, 30906 |
19473 |
0.26 |
chr17_29094634_29094798 | 1.86 |
1700023B13Rik |
RIKEN cDNA 1700023B13 gene |
255 |
0.77 |
chr3_105705277_105705434 | 1.85 |
Inka2 |
inka box actin regulator 2 |
103 |
0.95 |
chr4_148084251_148084540 | 1.85 |
Agtrap |
angiotensin II, type I receptor-associated protein |
381 |
0.73 |
chr1_39194066_39194239 | 1.85 |
Npas2 |
neuronal PAS domain protein 2 |
60 |
0.97 |
chr7_113239438_113239767 | 1.84 |
Arntl |
aryl hydrocarbon receptor nuclear translocator-like |
152 |
0.96 |
chr19_47314767_47314938 | 1.84 |
Sh3pxd2a |
SH3 and PX domains 2A |
101 |
0.97 |
chr13_93630535_93630727 | 1.83 |
Gm15622 |
predicted gene 15622 |
5249 |
0.17 |
chr8_36188825_36189008 | 1.83 |
Gm35520 |
predicted gene, 35520 |
544 |
0.72 |
chr3_59006560_59006721 | 1.83 |
Med12l |
mediator complex subunit 12-like |
153 |
0.8 |
chr9_121912346_121912498 | 1.83 |
Cyp8b1 |
cytochrome P450, family 8, subfamily b, polypeptide 1 |
3883 |
0.1 |
chr2_103850440_103850628 | 1.83 |
Gm13879 |
predicted gene 13879 |
6878 |
0.09 |
chr4_148149701_148149870 | 1.82 |
Fbxo6 |
F-box protein 6 |
66 |
0.94 |
chr14_41153241_41153864 | 1.82 |
Mbl1 |
mannose-binding lectin (protein A) 1 |
2051 |
0.2 |
chr5_52977937_52978088 | 1.82 |
Gm30301 |
predicted gene, 30301 |
4025 |
0.18 |
chr17_30609874_30610226 | 1.81 |
Glo1 |
glyoxalase 1 |
2519 |
0.15 |
chrY_90767713_90768012 | 1.81 |
Gm21860 |
predicted gene, 21860 |
12395 |
0.17 |
chr13_28531675_28531858 | 1.80 |
2610307P16Rik |
RIKEN cDNA 2610307P16 gene |
10658 |
0.23 |
chr13_93618232_93618425 | 1.80 |
Gm15622 |
predicted gene 15622 |
7054 |
0.17 |
chr1_72790444_72790955 | 1.80 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
33804 |
0.15 |
chr11_112810941_112811143 | 1.80 |
Gm11681 |
predicted gene 11681 |
12034 |
0.18 |
chr9_95563216_95563775 | 1.80 |
Paqr9 |
progestin and adipoQ receptor family member IX |
3838 |
0.16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 14.2 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
3.7 | 11.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
2.9 | 14.5 | GO:0072675 | osteoclast fusion(GO:0072675) |
2.8 | 8.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
2.8 | 8.3 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
2.2 | 6.5 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.9 | 5.8 | GO:0070384 | Harderian gland development(GO:0070384) |
1.9 | 7.4 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.8 | 9.0 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
1.7 | 5.2 | GO:0065001 | specification of axis polarity(GO:0065001) |
1.7 | 1.7 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
1.6 | 4.9 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.6 | 6.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.5 | 4.6 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.5 | 4.6 | GO:0045472 | response to ether(GO:0045472) |
1.5 | 9.0 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
1.4 | 6.8 | GO:0009115 | xanthine catabolic process(GO:0009115) |
1.3 | 4.0 | GO:0030242 | pexophagy(GO:0030242) |
1.3 | 5.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
1.3 | 3.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.3 | 5.1 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
1.2 | 5.0 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.2 | 7.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
1.2 | 4.9 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.2 | 4.9 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
1.2 | 3.6 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.2 | 2.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.2 | 4.8 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
1.2 | 4.8 | GO:0007296 | vitellogenesis(GO:0007296) |
1.2 | 3.6 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
1.2 | 3.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.2 | 7.0 | GO:0051775 | response to redox state(GO:0051775) |
1.1 | 3.4 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
1.1 | 12.5 | GO:0007097 | nuclear migration(GO:0007097) |
1.1 | 3.4 | GO:0002432 | granuloma formation(GO:0002432) |
1.1 | 27.0 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
1.1 | 3.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.1 | 1.1 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
1.1 | 4.4 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.1 | 5.5 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.1 | 3.3 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.1 | 3.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.1 | 5.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.1 | 2.1 | GO:0048382 | mesendoderm development(GO:0048382) |
1.1 | 2.1 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
1.1 | 3.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
1.0 | 3.1 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.0 | 1.0 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
1.0 | 4.2 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
1.0 | 7.2 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
1.0 | 2.0 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.0 | 4.0 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
1.0 | 4.0 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
1.0 | 2.9 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
1.0 | 2.0 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
1.0 | 1.9 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
1.0 | 1.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.0 | 2.9 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
1.0 | 1.9 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
1.0 | 5.8 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
1.0 | 3.8 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
0.9 | 2.8 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.9 | 2.7 | GO:0035564 | regulation of kidney size(GO:0035564) |
0.9 | 2.7 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.9 | 2.7 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.9 | 3.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.9 | 2.7 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.9 | 2.7 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.9 | 2.7 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.9 | 3.5 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.9 | 6.2 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.9 | 2.7 | GO:0003032 | detection of oxygen(GO:0003032) |
0.9 | 1.8 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.9 | 7.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.9 | 5.2 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.9 | 3.5 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.9 | 4.3 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.9 | 2.6 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.9 | 4.3 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.8 | 5.9 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.8 | 2.5 | GO:0015744 | succinate transport(GO:0015744) |
0.8 | 1.7 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.8 | 2.5 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.8 | 4.2 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.8 | 1.7 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.8 | 2.5 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.8 | 1.6 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.8 | 3.3 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.8 | 6.5 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.8 | 4.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.8 | 3.2 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.8 | 4.0 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.8 | 2.4 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.8 | 4.0 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.8 | 6.4 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.8 | 5.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.8 | 3.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.8 | 0.8 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.8 | 3.2 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.8 | 0.8 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.8 | 3.2 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.8 | 0.8 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.8 | 1.6 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.8 | 6.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.8 | 3.9 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.8 | 3.1 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.8 | 2.3 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.8 | 3.9 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
0.8 | 1.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.8 | 2.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.8 | 2.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.8 | 3.8 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.8 | 3.1 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.8 | 1.5 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.8 | 3.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.8 | 2.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.8 | 2.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.8 | 0.8 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.8 | 1.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.8 | 3.0 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.8 | 1.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.7 | 3.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.7 | 9.0 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.7 | 3.0 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.7 | 8.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.7 | 5.1 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.7 | 2.2 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.7 | 2.2 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.7 | 5.8 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.7 | 1.4 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.7 | 2.9 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.7 | 2.2 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.7 | 1.4 | GO:0034443 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
0.7 | 2.1 | GO:0097503 | sialylation(GO:0097503) |
0.7 | 2.8 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.7 | 0.7 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.7 | 4.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.7 | 0.7 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.7 | 0.7 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.7 | 2.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.7 | 0.7 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.7 | 2.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.7 | 2.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.7 | 2.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.7 | 2.0 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.7 | 4.8 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.7 | 2.0 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.7 | 2.0 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.7 | 6.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.7 | 3.3 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.7 | 4.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.7 | 1.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.7 | 4.0 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.7 | 8.6 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.7 | 0.7 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.7 | 2.0 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.7 | 0.7 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.7 | 1.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.7 | 2.0 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.6 | 1.9 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.6 | 0.6 | GO:0043382 | regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) |
0.6 | 5.2 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.6 | 8.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.6 | 8.4 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.6 | 2.6 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.6 | 2.6 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.6 | 1.3 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.6 | 3.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.6 | 1.9 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.6 | 1.9 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.6 | 0.6 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.6 | 2.5 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.6 | 0.6 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.6 | 0.6 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.6 | 1.9 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.6 | 3.7 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.6 | 2.5 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.6 | 3.1 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) |
0.6 | 0.6 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.6 | 6.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.6 | 1.8 | GO:0021586 | pons maturation(GO:0021586) |
0.6 | 1.8 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.6 | 2.4 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.6 | 5.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.6 | 2.4 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.6 | 3.0 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.6 | 0.6 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.6 | 1.8 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.6 | 1.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.6 | 3.0 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.6 | 1.8 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.6 | 1.8 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.6 | 1.8 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.6 | 1.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.6 | 1.2 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.6 | 1.7 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.6 | 2.3 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.6 | 2.3 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.6 | 0.6 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.6 | 0.6 | GO:0002339 | B cell selection(GO:0002339) |
0.6 | 1.1 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.6 | 1.7 | GO:0060066 | oviduct development(GO:0060066) |
0.6 | 1.1 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.6 | 1.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.6 | 3.9 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.6 | 0.6 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.6 | 4.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 1.7 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.6 | 1.7 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.6 | 3.9 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.6 | 1.7 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.6 | 1.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.6 | 1.1 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.5 | 6.0 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.5 | 2.7 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.5 | 1.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.5 | 0.5 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.5 | 1.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.5 | 2.7 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.5 | 1.1 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.5 | 3.2 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.5 | 1.1 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.5 | 2.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.5 | 1.6 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.5 | 2.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.5 | 1.1 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.5 | 2.1 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.5 | 3.7 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.5 | 2.1 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.5 | 1.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.5 | 1.6 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.5 | 1.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.5 | 1.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.5 | 1.6 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.5 | 1.1 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.5 | 0.5 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.5 | 3.1 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.5 | 3.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.5 | 3.1 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.5 | 0.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.5 | 7.8 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.5 | 3.1 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.5 | 1.5 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.5 | 3.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.5 | 1.0 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.5 | 2.0 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.5 | 3.6 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.5 | 1.5 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.5 | 1.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.5 | 1.5 | GO:0035973 | aggrephagy(GO:0035973) |
0.5 | 1.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.5 | 3.0 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.5 | 2.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.5 | 2.5 | GO:0015871 | choline transport(GO:0015871) |
0.5 | 2.0 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.5 | 2.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.5 | 2.5 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.5 | 2.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.5 | 0.5 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.5 | 0.5 | GO:0015755 | fructose transport(GO:0015755) |
0.5 | 1.5 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.5 | 2.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.5 | 1.5 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.5 | 0.5 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.5 | 4.4 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.5 | 1.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.5 | 1.5 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.5 | 1.9 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.5 | 1.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.5 | 1.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.5 | 1.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.5 | 0.5 | GO:0090170 | trachea formation(GO:0060440) regulation of Golgi inheritance(GO:0090170) |
0.5 | 5.8 | GO:0051601 | exocyst localization(GO:0051601) |
0.5 | 1.0 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.5 | 1.4 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.5 | 4.8 | GO:1904385 | angiotensin-activated signaling pathway(GO:0038166) cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.5 | 1.4 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.5 | 1.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.5 | 0.5 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.5 | 0.5 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.5 | 1.4 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.5 | 1.4 | GO:0008050 | female courtship behavior(GO:0008050) |
0.5 | 1.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.5 | 3.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.5 | 2.8 | GO:0006477 | protein sulfation(GO:0006477) |
0.5 | 2.8 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.5 | 1.9 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.5 | 2.8 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.5 | 0.9 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.5 | 0.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.5 | 1.4 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.5 | 1.4 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.5 | 0.9 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.5 | 2.3 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.5 | 1.9 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.5 | 0.9 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.5 | 0.5 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.5 | 0.5 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.5 | 0.5 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.5 | 5.0 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.5 | 1.8 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.5 | 1.4 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.5 | 3.2 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.5 | 0.5 | GO:1903797 | regulation of inorganic anion transmembrane transport(GO:1903795) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.5 | 1.4 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.5 | 1.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.5 | 2.3 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.5 | 0.5 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.4 | 3.1 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.4 | 3.1 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.4 | 1.3 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.4 | 0.9 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.4 | 1.3 | GO:0009414 | response to water deprivation(GO:0009414) |
0.4 | 5.3 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.4 | 0.4 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.4 | 1.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.4 | 2.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.4 | 2.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.4 | 1.3 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.4 | 1.3 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.4 | 3.1 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.4 | 0.4 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.4 | 2.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.4 | 1.7 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.4 | 4.8 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
0.4 | 1.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.4 | 1.3 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.4 | 0.4 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.4 | 0.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.4 | 0.9 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.4 | 1.7 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.4 | 3.0 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.4 | 4.7 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.4 | 0.9 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.4 | 2.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 1.3 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.4 | 5.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.4 | 1.7 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.4 | 0.8 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.4 | 0.8 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.4 | 2.5 | GO:0051013 | microtubule severing(GO:0051013) |
0.4 | 10.1 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.4 | 0.8 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.4 | 1.7 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.4 | 0.4 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.4 | 2.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.4 | 2.1 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.4 | 2.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.4 | 2.5 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.4 | 2.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.4 | 3.3 | GO:0046697 | decidualization(GO:0046697) |
0.4 | 0.4 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.4 | 0.8 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.4 | 0.4 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.4 | 1.6 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.4 | 1.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.4 | 3.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.4 | 0.8 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.4 | 1.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.4 | 0.8 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.4 | 2.0 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.4 | 0.4 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.4 | 1.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.4 | 0.8 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.4 | 0.4 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.4 | 0.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.4 | 1.6 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.4 | 0.8 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.4 | 0.8 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.4 | 0.4 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.4 | 4.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.4 | 2.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.4 | 0.4 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.4 | 1.6 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.4 | 0.4 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.4 | 2.0 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.4 | 0.8 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.4 | 1.6 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.4 | 0.8 | GO:0015888 | thiamine transport(GO:0015888) |
0.4 | 0.8 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.4 | 0.4 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.4 | 1.2 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.4 | 0.8 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.4 | 3.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.4 | 1.9 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.4 | 1.9 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.4 | 0.8 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.4 | 0.8 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.4 | 1.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.4 | 2.3 | GO:0043371 | negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) negative regulation of T-helper cell differentiation(GO:0045623) |
0.4 | 3.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.4 | 2.3 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.4 | 0.4 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.4 | 1.9 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.4 | 0.4 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.4 | 0.4 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.4 | 6.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.4 | 3.0 | GO:0016559 | peroxisome fission(GO:0016559) |
0.4 | 1.5 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.4 | 0.4 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.4 | 0.4 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.4 | 1.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.4 | 1.9 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.4 | 4.5 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.4 | 1.5 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.4 | 12.1 | GO:0033141 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.4 | 0.4 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.4 | 1.1 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.4 | 3.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.4 | 1.1 | GO:1904938 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.4 | 0.7 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.4 | 4.1 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.4 | 1.9 | GO:0046836 | glycolipid transport(GO:0046836) |
0.4 | 0.4 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.4 | 0.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.4 | 2.2 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.4 | 1.5 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.4 | 1.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.4 | 0.4 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.4 | 2.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.4 | 2.9 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.4 | 0.7 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.4 | 0.7 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.4 | 1.8 | GO:0035878 | nail development(GO:0035878) |
0.4 | 1.4 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.4 | 0.7 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.4 | 0.4 | GO:1901991 | negative regulation of mitotic cell cycle phase transition(GO:1901991) |
0.4 | 0.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 1.1 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.4 | 0.7 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.4 | 1.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.4 | 0.7 | GO:1902547 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.4 | 1.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 17.2 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.3 | 1.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.3 | 2.1 | GO:0060770 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.3 | 2.1 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.3 | 0.7 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.3 | 0.3 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.3 | 1.0 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.3 | 0.7 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.3 | 3.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.3 | 1.0 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.3 | 1.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.3 | 3.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.3 | 1.4 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.3 | 3.1 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.3 | 0.3 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.3 | 1.0 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 1.4 | GO:0015825 | L-serine transport(GO:0015825) |
0.3 | 0.7 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.3 | 1.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 1.0 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.3 | 0.3 | GO:0051795 | regulation of catagen(GO:0051794) positive regulation of catagen(GO:0051795) |
0.3 | 1.4 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.3 | 1.0 | GO:2000301 | negative regulation of synaptic vesicle transport(GO:1902804) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.3 | 1.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.3 | 2.4 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.3 | 0.3 | GO:0001927 | exocyst assembly(GO:0001927) |
0.3 | 1.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.3 | 3.7 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.3 | 1.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.3 | 3.7 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.3 | 1.3 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.3 | 3.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.3 | 1.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 0.3 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.3 | 1.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.3 | 0.7 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.3 | 4.0 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.3 | 2.0 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.3 | 2.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.3 | 1.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 2.3 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.3 | 0.7 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
0.3 | 3.3 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.3 | 2.0 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.3 | 1.0 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.3 | 2.3 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.3 | 0.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.3 | 4.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 1.3 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.3 | 0.6 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.3 | 0.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 1.9 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.3 | 1.6 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 0.6 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.3 | 1.0 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.3 | 0.6 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 2.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.3 | 1.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.3 | 0.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.3 | 0.3 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.3 | 0.6 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.3 | 0.3 | GO:0061205 | paramesonephric duct development(GO:0061205) |
0.3 | 0.6 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.3 | 0.3 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.3 | 6.6 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.3 | 0.6 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.3 | 0.9 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 0.6 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.3 | 1.6 | GO:0000012 | single strand break repair(GO:0000012) |
0.3 | 1.3 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.3 | 0.3 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.3 | 2.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.3 | 2.8 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.3 | 0.3 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.3 | 0.6 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.3 | 2.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.3 | 0.9 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.3 | 0.3 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.3 | 1.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 1.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.3 | 0.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.3 | 3.1 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.3 | 0.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 0.3 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.3 | 0.9 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.3 | 1.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 0.6 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.3 | 0.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.3 | 1.8 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.3 | 1.2 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.3 | 1.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.3 | 0.6 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.3 | 0.6 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.3 | 1.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 0.9 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.3 | 3.6 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 0.3 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.3 | 0.9 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.3 | 0.6 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.3 | 0.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 1.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.3 | 0.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.3 | 0.9 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.3 | 1.5 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.3 | 2.1 | GO:0071385 | cellular response to glucocorticoid stimulus(GO:0071385) |
0.3 | 0.6 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.3 | 1.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.3 | 4.1 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.3 | 0.6 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.3 | 0.3 | GO:0009757 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.3 | 1.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 1.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.3 | 0.6 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.3 | 0.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.3 | 0.3 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.3 | 0.9 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 0.9 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.3 | 1.4 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.3 | 0.3 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.3 | 1.1 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.3 | 0.3 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.3 | 0.9 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.3 | 0.6 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.3 | 2.3 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.3 | 1.7 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.3 | 0.3 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.3 | 0.3 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.3 | 1.7 | GO:0016322 | neuron remodeling(GO:0016322) |
0.3 | 2.0 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.3 | 0.6 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.3 | 0.6 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.3 | 0.6 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.3 | 1.7 | GO:0033572 | transferrin transport(GO:0033572) |
0.3 | 0.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.3 | 0.8 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.3 | 0.6 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.3 | 0.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.3 | 0.8 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 0.6 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.3 | 0.6 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.3 | 1.4 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.3 | 0.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.3 | 0.3 | GO:0015747 | urate transport(GO:0015747) |
0.3 | 0.6 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.3 | 0.3 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
0.3 | 0.8 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 0.8 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
0.3 | 0.5 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.3 | 1.1 | GO:0090382 | phagosome maturation(GO:0090382) |
0.3 | 1.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.3 | 0.3 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.3 | 2.4 | GO:0002076 | osteoblast development(GO:0002076) |
0.3 | 0.5 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.3 | 0.5 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.3 | 3.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 5.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.3 | 0.8 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.3 | 0.5 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.3 | 1.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.3 | 0.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.3 | 1.1 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.3 | 0.3 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.3 | 0.5 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.3 | 0.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.3 | 0.3 | GO:0010165 | response to X-ray(GO:0010165) |
0.3 | 0.8 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.3 | 1.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 0.8 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.3 | 0.5 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.3 | 0.8 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.3 | 0.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.3 | 1.0 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.3 | 1.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.3 | 1.3 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.3 | 0.8 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.3 | 1.0 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.3 | 1.8 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.3 | 3.4 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.3 | 0.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.3 | 0.5 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.3 | 0.3 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.3 | 1.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.3 | 0.5 | GO:0035482 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
0.3 | 1.8 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 0.8 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.3 | 1.8 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.3 | 0.3 | GO:0030837 | negative regulation of actin filament polymerization(GO:0030837) |
0.3 | 2.5 | GO:0051642 | centrosome localization(GO:0051642) |
0.3 | 1.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.3 | 1.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.3 | 1.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.3 | 1.0 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.3 | 0.5 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.3 | 0.8 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.3 | 0.8 | GO:0061511 | centriole elongation(GO:0061511) |
0.3 | 0.3 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.3 | 3.8 | GO:0048535 | lymph node development(GO:0048535) |
0.3 | 0.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 0.5 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.2 | 0.7 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.2 | 1.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 0.7 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 2.7 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.2 | 0.7 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.2 | 1.2 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.2 | 3.7 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.2 | 3.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.5 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.2 | 0.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 0.7 | GO:0008354 | germ cell migration(GO:0008354) |
0.2 | 1.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.2 | 2.4 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.2 | 3.4 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.2 | 0.5 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.2 | 7.0 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.2 | 1.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 4.3 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.2 | 0.7 | GO:0040031 | snRNA modification(GO:0040031) |
0.2 | 0.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.5 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 0.2 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.2 | 0.7 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.2 | 0.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 0.7 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.2 | 0.7 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.2 | 0.2 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.2 | 0.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 4.0 | GO:0042439 | ethanolamine-containing compound metabolic process(GO:0042439) |
0.2 | 0.7 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.2 | 0.2 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.2 | 0.5 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.2 | 0.9 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.2 | 1.9 | GO:0001706 | endoderm formation(GO:0001706) |
0.2 | 0.7 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.2 | 0.2 | GO:0090656 | t-circle formation(GO:0090656) |
0.2 | 0.7 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.2 | 1.9 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.7 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.5 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 1.4 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.2 | 0.5 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.2 | 0.9 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.2 | 0.2 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.2 | 0.7 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 0.5 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 0.2 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.2 | 1.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 0.5 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.2 | 1.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.7 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.2 | 0.5 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.2 | 0.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 2.9 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.2 | 0.7 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.2 | 0.2 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.2 | 0.2 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.2 | 3.6 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.2 | 0.7 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.2 | 1.4 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.2 | 2.0 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.2 | 0.9 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.2 | 0.9 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.2 | 0.7 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.2 | 2.5 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.2 | 1.3 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.2 | 1.6 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 0.9 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.2 | 0.7 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 2.9 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 0.9 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.2 | 1.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.2 | 0.4 | GO:2000002 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
0.2 | 0.7 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 1.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 0.2 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 0.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 0.4 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.2 | 1.7 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.2 | 0.9 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.2 | 0.2 | GO:0098930 | axonal transport(GO:0098930) |
0.2 | 0.4 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.2 | 0.6 | GO:2000303 | regulation of ceramide biosynthetic process(GO:2000303) |
0.2 | 0.4 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 0.2 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.2 | 1.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 2.5 | GO:0001967 | suckling behavior(GO:0001967) |
0.2 | 2.3 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.2 | 2.5 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.2 | 0.4 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.2 | 0.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 2.5 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 0.6 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 0.6 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 0.8 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.2 | 1.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 0.6 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.2 | 0.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 1.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.2 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.2 | 0.2 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.2 | 0.2 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.2 | 0.2 | GO:0051665 | membrane raft localization(GO:0051665) |
0.2 | 0.4 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.2 | 0.8 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 0.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 0.2 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.2 | 0.4 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 2.8 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 2.2 | GO:0015858 | nucleoside transport(GO:0015858) |
0.2 | 1.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 1.0 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.2 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 1.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 0.6 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.2 | 0.6 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.2 | 0.6 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 0.8 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.2 | 0.6 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.2 | 2.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.2 | 2.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.2 | 1.2 | GO:0070862 | regulation of protein exit from endoplasmic reticulum(GO:0070861) negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 0.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.2 | 0.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.2 | 0.4 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 1.2 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.2 | 0.2 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.2 | 0.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 0.2 | GO:0007619 | courtship behavior(GO:0007619) |
0.2 | 0.6 | GO:0044849 | estrous cycle(GO:0044849) |
0.2 | 0.4 | GO:0090148 | membrane fission(GO:0090148) |
0.2 | 1.6 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.6 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.2 | 1.8 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.2 | 1.0 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 2.5 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.2 | 0.4 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.2 | 0.6 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 3.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.2 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.2 | 0.2 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.2 | 0.2 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) |
0.2 | 1.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 2.5 | GO:0002021 | response to dietary excess(GO:0002021) |
0.2 | 0.2 | GO:0032762 | mast cell cytokine production(GO:0032762) |
0.2 | 0.8 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.2 | 3.8 | GO:1902668 | negative regulation of axon guidance(GO:1902668) |
0.2 | 0.6 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.2 | 0.8 | GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
0.2 | 0.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 0.2 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 0.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.8 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.2 | 0.6 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.2 | 0.7 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.2 | 0.4 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 0.7 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 0.2 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.2 | 0.6 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 0.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 0.2 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.2 | 0.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 0.2 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 0.2 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.2 | 0.7 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 2.9 | GO:0043297 | apical junction assembly(GO:0043297) |
0.2 | 0.4 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.2 | 5.2 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 0.4 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.2 | 0.2 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.2 | 0.9 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 0.9 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.2 | 0.5 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 0.4 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.2 | 0.4 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 0.4 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.2 | 0.4 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 0.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 0.7 | GO:0003352 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.2 | 0.4 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.2 | 1.2 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 0.5 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.2 | 0.2 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.2 | 1.2 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.2 | 0.5 | GO:0060914 | heart formation(GO:0060914) |
0.2 | 2.5 | GO:0042246 | tissue regeneration(GO:0042246) |
0.2 | 1.6 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.7 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 0.9 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 2.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 0.2 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.2 | 0.2 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.2 | 0.3 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 0.9 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 5.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 0.5 | GO:0050996 | positive regulation of lipid catabolic process(GO:0050996) |
0.2 | 0.2 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.2 | 1.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.2 | 0.5 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 3.8 | GO:0006284 | base-excision repair(GO:0006284) |
0.2 | 0.7 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.3 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 0.2 | GO:0046666 | retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
0.2 | 1.0 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.2 | 0.5 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 0.7 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.2 | 0.3 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.2 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 1.0 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 0.3 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.2 | 0.2 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.2 | 0.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 1.7 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 1.2 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.2 | 0.8 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.2 | 0.8 | GO:0006689 | ganglioside catabolic process(GO:0006689) glycosphingolipid catabolic process(GO:0046479) |
0.2 | 1.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 0.7 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.2 | 1.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 1.0 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.2 | 0.7 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 3.1 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.2 | 0.7 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.2 | 2.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 0.2 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.2 | 0.5 | GO:0046541 | saliva secretion(GO:0046541) |
0.2 | 0.7 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.2 | 0.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.2 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.2 | 0.5 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.2 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.2 | 0.5 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.2 | 1.5 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.2 | 0.5 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.2 | 0.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.2 | 0.8 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.2 | 0.6 | GO:0009650 | UV protection(GO:0009650) |
0.2 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.6 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 0.8 | GO:0042640 | anagen(GO:0042640) |
0.2 | 0.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 0.3 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 1.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.5 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.2 | 0.2 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.2 | 1.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.2 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.2 | 0.5 | GO:0032288 | myelin assembly(GO:0032288) |
0.2 | 1.6 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.2 | 1.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 1.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.2 | 0.9 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 1.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.9 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.2 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 0.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.2 | 0.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.2 | 0.5 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
0.2 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 2.0 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.2 | 0.5 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 0.6 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.2 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.2 | 0.3 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.2 | 0.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.3 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.4 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 1.8 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.1 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.1 | 0.3 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.1 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.1 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 0.1 | GO:0051653 | spindle localization(GO:0051653) |
0.1 | 1.2 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.1 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.4 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.1 | 0.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 1.3 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 1.5 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
0.1 | 6.4 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 0.3 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.1 | 1.3 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.1 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 1.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.6 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.1 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.1 | 0.3 | GO:0007143 | female meiotic division(GO:0007143) |
0.1 | 1.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.1 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 0.9 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.1 | 0.4 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.1 | 0.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.1 | 11.3 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.1 | 0.6 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.4 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 1.5 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.1 | 3.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 1.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.3 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.1 | 0.1 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.1 | 0.6 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.1 | 1.2 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.1 | GO:0044026 | DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
0.1 | 0.3 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
0.1 | 0.1 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.1 | 0.7 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 1.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.1 | GO:1902307 | positive regulation of sodium ion transmembrane transport(GO:1902307) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.3 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 0.1 | GO:1903364 | positive regulation of cellular protein catabolic process(GO:1903364) |
0.1 | 0.3 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.1 | 1.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.4 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.8 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.1 | 0.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.4 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.1 | 0.5 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.4 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.3 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 6.6 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 2.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.5 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 1.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.9 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 1.1 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 1.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.5 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.1 | 0.3 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.1 | 0.8 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 1.0 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.1 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.1 | 0.3 | GO:0072757 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.1 | 0.5 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 0.1 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 1.4 | GO:0009409 | response to cold(GO:0009409) |
0.1 | 0.8 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 3.1 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 1.2 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.6 | GO:0071450 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.1 | 0.1 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.5 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.4 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.9 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.4 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.6 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.4 | GO:0030728 | ovulation(GO:0030728) |
0.1 | 0.4 | GO:1903624 | regulation of DNA catabolic process(GO:1903624) |
0.1 | 0.7 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.9 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 0.7 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.1 | 2.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 1.4 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.2 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 3.7 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 1.2 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.1 | 1.7 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.1 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.1 | 0.5 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 0.6 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.9 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.8 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.1 | 0.1 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.1 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.1 | 0.1 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.1 | 0.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 1.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.1 | 1.3 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.9 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.1 | 0.2 | GO:0014831 | gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.1 | 0.3 | GO:0060717 | chorion development(GO:0060717) chorionic trophoblast cell differentiation(GO:0060718) extraembryonic membrane development(GO:1903867) |
0.1 | 0.2 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 0.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.3 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.1 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.1 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.1 | 3.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.2 | GO:0070922 | small RNA loading onto RISC(GO:0070922) |
0.1 | 0.7 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 1.0 | GO:0060384 | innervation(GO:0060384) |
0.1 | 0.3 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.1 | 1.5 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.3 | GO:0060044 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.1 | 0.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.7 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.1 | 0.5 | GO:0043584 | nose development(GO:0043584) |
0.1 | 0.1 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.1 | 0.5 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.2 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.1 | 0.3 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.1 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 0.4 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.1 | 1.7 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.7 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 1.3 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.5 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.5 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 0.6 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 1.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 1.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.8 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.6 | GO:0032400 | melanosome localization(GO:0032400) |
0.1 | 0.5 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 0.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.5 | GO:0051893 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) |
0.1 | 0.4 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.1 | 0.8 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.1 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.1 | 0.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.2 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.1 | 0.7 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.3 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.2 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.4 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.3 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.1 | 1.4 | GO:2000573 | positive regulation of DNA biosynthetic process(GO:2000573) |
0.1 | 0.7 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.1 | 0.1 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 0.2 | GO:1901797 | negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.1 | 0.4 | GO:0071514 | genetic imprinting(GO:0071514) |
0.1 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 1.7 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.1 | 0.1 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.1 | 2.8 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.1 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.1 | 1.6 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.6 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.4 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.5 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 0.5 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.4 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.1 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.1 | 1.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.1 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.1 | 0.2 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.2 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.5 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.1 | GO:0086011 | membrane repolarization during action potential(GO:0086011) |
0.1 | 0.3 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.1 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.1 | 0.2 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.1 | 0.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 0.1 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.4 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.1 | 0.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 1.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.2 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.1 | 0.3 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.1 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.1 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.1 | 0.4 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.2 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.1 | 0.6 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.4 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.4 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.1 | 0.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.2 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.1 | 0.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.7 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.1 | 0.1 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.1 | 1.0 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.1 | 0.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.4 | GO:0099622 | cardiac muscle cell membrane repolarization(GO:0099622) |
0.1 | 0.8 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.1 | 1.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.3 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.2 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.2 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 1.0 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.2 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 1.1 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.1 | 0.4 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.1 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.3 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.2 | GO:0061647 | histone H3-K9 modification(GO:0061647) |
0.1 | 0.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.1 | 0.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 1.6 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.1 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.1 | GO:0033523 | positive regulation of histone ubiquitination(GO:0033184) histone H2B ubiquitination(GO:0033523) |
0.1 | 0.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.5 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.1 | GO:0051610 | serotonin uptake(GO:0051610) |
0.1 | 0.1 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.1 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.1 | 4.5 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.1 | 0.2 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.1 | 0.4 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.1 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.4 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.1 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.1 | 0.4 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.1 | 0.3 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 1.5 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.2 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.6 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.7 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.1 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.3 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.1 | 1.0 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.2 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.3 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.1 | 0.3 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 1.7 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.1 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
0.1 | 1.4 | GO:0010950 | positive regulation of endopeptidase activity(GO:0010950) |
0.1 | 0.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.1 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.1 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.1 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 1.3 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.4 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.1 | 1.9 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.2 | GO:1903543 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.1 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.1 | 0.6 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.1 | 0.2 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.3 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.1 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.2 | GO:0032196 | transposition(GO:0032196) |
0.1 | 0.1 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.1 | 1.3 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 0.8 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.1 | 0.2 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.1 | GO:0044362 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) modulation by symbiont of host molecular function(GO:0052055) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) |
0.1 | 0.2 | GO:0071042 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.1 | 0.6 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.6 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.1 | 0.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.2 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.1 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.1 | 0.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.7 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 0.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.3 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.1 | 0.4 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 0.1 | GO:0072071 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
0.1 | 0.1 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.1 | 0.1 | GO:0051580 | regulation of neurotransmitter uptake(GO:0051580) |
0.1 | 0.2 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.1 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.1 | 0.5 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.1 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.2 | GO:0002385 | mucosal immune response(GO:0002385) |
0.1 | 0.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.1 | 0.1 | GO:0090241 | regulation of histone H4 acetylation(GO:0090239) negative regulation of histone H4 acetylation(GO:0090241) |
0.0 | 0.0 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.0 | 0.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 1.1 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.1 | GO:1902622 | regulation of neutrophil migration(GO:1902622) |
0.0 | 0.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 1.3 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.0 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.0 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.8 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.2 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 1.0 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.0 | 0.8 | GO:0030816 | positive regulation of cAMP metabolic process(GO:0030816) |
0.0 | 0.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.0 | 0.3 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.1 | GO:0046386 | deoxyribose phosphate catabolic process(GO:0046386) |
0.0 | 0.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 0.0 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.0 | 0.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.0 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.0 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) positive regulation of chemokine secretion(GO:0090197) |
0.0 | 0.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.0 | 0.0 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.0 | 1.2 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
0.0 | 0.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 0.5 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.0 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.6 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.0 | 0.0 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.0 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.3 | GO:0050779 | RNA destabilization(GO:0050779) |
0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.3 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.0 | 0.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.2 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.0 | 0.1 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.0 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.0 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.0 | 0.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.0 | GO:0007418 | ventral midline development(GO:0007418) |
0.0 | 0.3 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.5 | GO:0035904 | aorta development(GO:0035904) |
0.0 | 0.0 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.0 | 0.0 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.1 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.0 | 0.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.1 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.0 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.0 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.0 | 0.1 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.0 | 1.7 | GO:0007051 | spindle organization(GO:0007051) |
0.0 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.0 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.0 | 0.7 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.0 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.0 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.3 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.0 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.1 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.2 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.0 | 0.1 | GO:0070091 | glucagon secretion(GO:0070091) |
0.0 | 0.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.0 | 0.0 | GO:0072074 | kidney mesenchyme development(GO:0072074) |
0.0 | 0.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.0 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.0 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.0 | 0.3 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.4 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 0.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.0 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.0 | 0.0 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
0.0 | 0.0 | GO:0051788 | response to misfolded protein(GO:0051788) cellular response to misfolded protein(GO:0071218) |
0.0 | 0.0 | GO:0048021 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.0 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.0 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.0 | GO:0034340 | response to type I interferon(GO:0034340) |
0.0 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.0 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.0 | 0.0 | GO:0090071 | regulation of ribosome biogenesis(GO:0090069) negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 1.9 | GO:0007059 | chromosome segregation(GO:0007059) |
0.0 | 0.0 | GO:0071863 | regulation of cell proliferation in bone marrow(GO:0071863) positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.0 | 0.0 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.0 | 0.1 | GO:0015669 | gas transport(GO:0015669) |
0.0 | 0.1 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.0 | 0.1 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.0 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.0 | 0.0 | GO:0030421 | defecation(GO:0030421) |
0.0 | 0.1 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) |
0.0 | 0.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.1 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.0 | 0.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.0 | 0.0 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.0 | 0.0 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.0 | 0.0 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.0 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.1 | GO:0002931 | response to ischemia(GO:0002931) |
0.0 | 0.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.0 | 0.2 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.0 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 0.0 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.0 | 0.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.2 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.0 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.0 | 0.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.6 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.0 | 0.1 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.0 | 0.0 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.0 | 0.0 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.0 | 0.1 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.5 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.0 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.0 | 0.0 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.0 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.0 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.0 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.1 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.0 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.1 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.0 | GO:0071435 | potassium ion export(GO:0071435) |
0.0 | 0.1 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.0 | 0.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.0 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 0.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.0 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.0 | 0.0 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) positive regulation of enamel mineralization(GO:0070175) |
0.0 | 0.0 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.1 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) |
0.0 | 0.0 | GO:0031649 | heat generation(GO:0031649) |
0.0 | 0.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 2.0 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
2.0 | 13.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.6 | 4.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.5 | 6.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.5 | 1.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.1 | 6.4 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
1.0 | 4.8 | GO:0033010 | paranodal junction(GO:0033010) |
1.0 | 2.9 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.9 | 2.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.9 | 3.6 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.9 | 1.8 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.9 | 2.6 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.9 | 2.6 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.8 | 0.8 | GO:0097513 | myosin II filament(GO:0097513) |
0.8 | 0.8 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.8 | 2.4 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.8 | 2.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.8 | 3.2 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.8 | 2.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.8 | 2.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.8 | 1.5 | GO:0099738 | basal cortex(GO:0045180) cell cortex region(GO:0099738) |
0.8 | 0.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.7 | 2.2 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.7 | 3.0 | GO:1990246 | uniplex complex(GO:1990246) |
0.7 | 2.2 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.7 | 0.7 | GO:0046930 | pore complex(GO:0046930) |
0.7 | 2.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.7 | 2.0 | GO:0097443 | sorting endosome(GO:0097443) |
0.6 | 3.2 | GO:0008091 | spectrin(GO:0008091) |
0.6 | 3.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.6 | 3.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.6 | 8.7 | GO:0033391 | chromatoid body(GO:0033391) |
0.6 | 3.6 | GO:0043219 | lateral loop(GO:0043219) |
0.6 | 2.4 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.6 | 0.6 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.6 | 3.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.6 | 2.9 | GO:0000235 | astral microtubule(GO:0000235) |
0.6 | 10.2 | GO:0002102 | podosome(GO:0002102) |
0.6 | 0.6 | GO:0044292 | dendrite terminus(GO:0044292) |
0.6 | 5.0 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.6 | 3.9 | GO:0030008 | TRAPP complex(GO:0030008) |
0.5 | 4.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.5 | 3.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 2.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.5 | 0.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.5 | 2.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.5 | 1.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.5 | 3.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.5 | 1.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.5 | 7.0 | GO:0000145 | exocyst(GO:0000145) |
0.5 | 1.0 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.5 | 1.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.5 | 1.0 | GO:0031090 | organelle membrane(GO:0031090) |
0.5 | 0.9 | GO:0032437 | cuticular plate(GO:0032437) |
0.5 | 1.4 | GO:0035061 | interchromatin granule(GO:0035061) |
0.5 | 1.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.5 | 1.8 | GO:0044194 | cytolytic granule(GO:0044194) |
0.5 | 2.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.5 | 15.4 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.4 | 2.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.4 | 1.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.4 | 1.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 2.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.4 | 1.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.4 | 2.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.4 | 2.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.4 | 1.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.4 | 2.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.4 | 1.7 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.4 | 1.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.4 | 2.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.4 | 0.4 | GO:0001726 | ruffle(GO:0001726) |
0.4 | 2.5 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.4 | 4.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.4 | 2.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.4 | 6.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.4 | 3.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 5.7 | GO:0071565 | nBAF complex(GO:0071565) |
0.4 | 2.0 | GO:0000805 | X chromosome(GO:0000805) |
0.4 | 1.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.4 | 3.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.4 | 0.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.4 | 2.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 2.6 | GO:0045120 | pronucleus(GO:0045120) |
0.4 | 1.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.4 | 1.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.4 | 2.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.4 | 4.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.4 | 0.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.4 | 3.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.4 | 1.4 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.4 | 1.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.4 | 1.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.4 | 2.2 | GO:0043203 | axon hillock(GO:0043203) |
0.4 | 1.1 | GO:0000811 | GINS complex(GO:0000811) |
0.4 | 3.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 0.7 | GO:0042585 | germinal vesicle(GO:0042585) |
0.4 | 3.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.4 | 1.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.4 | 7.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.4 | 17.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.4 | 2.5 | GO:0035102 | PRC1 complex(GO:0035102) |
0.4 | 6.7 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.4 | 0.4 | GO:1990696 | USH2 complex(GO:1990696) |
0.3 | 3.8 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 1.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 8.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 6.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.3 | 1.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.3 | 1.7 | GO:0005767 | secondary lysosome(GO:0005767) |
0.3 | 2.0 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.3 | 1.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 0.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 3.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 1.0 | GO:0043511 | inhibin complex(GO:0043511) |
0.3 | 1.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 3.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.3 | 3.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 7.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.3 | 0.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 0.9 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 3.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 3.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 3.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 4.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 1.5 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 3.3 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.3 | 1.5 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.3 | 2.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 1.8 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.3 | 2.1 | GO:0001939 | female pronucleus(GO:0001939) |
0.3 | 14.2 | GO:0032587 | ruffle membrane(GO:0032587) |
0.3 | 3.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.3 | 1.5 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.3 | 2.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 0.9 | GO:1990462 | omegasome(GO:1990462) |
0.3 | 3.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.3 | 2.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.3 | 1.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.3 | 1.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 3.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.3 | 1.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.3 | 0.8 | GO:0043197 | dendritic spine(GO:0043197) |
0.3 | 0.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.3 | 1.9 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.3 | 0.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 9.6 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 0.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.3 | 7.6 | GO:0032590 | dendrite membrane(GO:0032590) |
0.3 | 0.5 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.3 | 1.3 | GO:0014704 | intercalated disc(GO:0014704) |
0.3 | 0.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 1.6 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 0.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.3 | 4.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.3 | 0.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 0.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 3.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 0.8 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.3 | 0.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.3 | 1.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 18.2 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.3 | 1.3 | GO:0005827 | polar microtubule(GO:0005827) |
0.3 | 0.8 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.3 | 2.3 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 0.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 1.0 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 5.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 0.2 | GO:0042827 | platelet dense granule(GO:0042827) |
0.2 | 0.5 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 0.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 0.5 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 3.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 1.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 1.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 3.6 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.2 | 0.2 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 0.5 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 1.9 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 0.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 0.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.2 | 3.7 | GO:0005903 | brush border(GO:0005903) |
0.2 | 0.7 | GO:0043194 | axon initial segment(GO:0043194) |
0.2 | 2.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 0.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 12.4 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 1.8 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 0.9 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 3.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 2.0 | GO:0036452 | ESCRT I complex(GO:0000813) ESCRT complex(GO:0036452) |
0.2 | 1.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 2.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 2.8 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 1.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 1.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 2.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 0.2 | GO:0044299 | C-fiber(GO:0044299) |
0.2 | 0.6 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 0.4 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 1.1 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 0.8 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 2.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 1.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 1.3 | GO:0005688 | U6 snRNP(GO:0005688) |
0.2 | 0.6 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 2.7 | GO:0038201 | TOR complex(GO:0038201) |
0.2 | 0.4 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 0.8 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 0.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 1.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 7.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 1.4 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 8.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 0.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 0.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.2 | 1.6 | GO:0043034 | costamere(GO:0043034) |
0.2 | 1.2 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 0.4 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.2 | 0.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.2 | 1.0 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 1.4 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 0.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 1.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 1.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 1.9 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 0.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 0.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 0.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 9.0 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 1.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 1.1 | GO:0000801 | central element(GO:0000801) |
0.2 | 0.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 1.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 0.7 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 1.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 0.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 9.7 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 0.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 6.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 0.5 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 1.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 1.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 0.5 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.3 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.2 | 4.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 2.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 1.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 0.7 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 1.2 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 4.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 1.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 0.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.5 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 0.5 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 5.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 0.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 3.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 0.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 0.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 0.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 5.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 0.6 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.2 | 5.5 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 0.5 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 5.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 1.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 0.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 3.8 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 0.6 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 1.4 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 1.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 1.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 1.2 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 2.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 1.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.1 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 1.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 1.2 | GO:0031430 | M band(GO:0031430) |
0.1 | 1.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.4 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 1.6 | GO:0031082 | BLOC complex(GO:0031082) |
0.1 | 3.7 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.7 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.7 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.3 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 3.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 4.8 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.7 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 2.1 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 1.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 6.0 | GO:0016605 | PML body(GO:0016605) |
0.1 | 4.3 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.3 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.5 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 2.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.9 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.5 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.3 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 33.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 1.4 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.1 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.1 | 1.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.9 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 7.0 | GO:0030496 | midbody(GO:0030496) |
0.1 | 7.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 1.0 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 1.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 1.2 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 9.6 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 2.1 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 1.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 4.2 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 1.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.5 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.2 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 5.0 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.1 | 1.2 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 2.0 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 1.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 2.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 3.5 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.1 | 0.3 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.6 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 11.5 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 5.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 3.9 | GO:0005901 | caveola(GO:0005901) |
0.1 | 1.5 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 0.6 | GO:0045202 | synapse(GO:0045202) |
0.1 | 2.4 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 5.3 | GO:0060076 | excitatory synapse(GO:0060076) |
0.1 | 0.6 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.4 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 5.4 | GO:0034705 | potassium channel complex(GO:0034705) |
0.1 | 0.6 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 1.4 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 1.0 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 6.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 2.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.5 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.9 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.1 | 0.6 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.1 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.5 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.4 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.1 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 0.4 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 16.0 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.4 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 1.7 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.7 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 5.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 0.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 1.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.7 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 8.9 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 6.7 | GO:0072372 | primary cilium(GO:0072372) |
0.1 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.5 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 1.1 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 2.9 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.1 | 0.2 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 0.9 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.4 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.1 | 1.5 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.1 | 4.0 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.1 | 1.8 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 2.8 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.2 | GO:0030894 | replisome(GO:0030894) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 5.5 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 0.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 115.6 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 1.6 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.7 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.3 | GO:0000792 | heterochromatin(GO:0000792) |
0.1 | 0.1 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 2.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 0.9 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 1.6 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 1.8 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.1 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.1 | 1.5 | GO:0005844 | polysome(GO:0005844) |
0.1 | 7.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.1 | GO:0044304 | main axon(GO:0044304) |
0.1 | 0.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 32.8 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 5.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.9 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.8 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.1 | 7.8 | GO:0005635 | nuclear envelope(GO:0005635) |
0.1 | 0.3 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 0.6 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 0.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.2 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.0 | 0.7 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.5 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 117.4 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.0 | 0.3 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 0.2 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.6 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.3 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 13.6 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 236.5 | GO:0005622 | intracellular(GO:0005622) |
0.0 | 9.2 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 2.8 | GO:0005886 | plasma membrane(GO:0005886) |
0.0 | 1.5 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 1.4 | GO:0016020 | membrane(GO:0016020) |
0.0 | 0.0 | GO:0012505 | endomembrane system(GO:0012505) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 8.8 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
2.5 | 7.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
2.5 | 7.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
2.2 | 8.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.9 | 13.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.9 | 15.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.5 | 7.7 | GO:0030151 | molybdenum ion binding(GO:0030151) |
1.4 | 2.9 | GO:0098811 | RNA polymerase II transcription coactivator activity(GO:0001105) transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
1.3 | 4.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.3 | 5.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.3 | 1.3 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
1.3 | 3.8 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
1.2 | 8.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
1.2 | 3.5 | GO:1990188 | euchromatin binding(GO:1990188) |
1.2 | 8.2 | GO:0018660 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.1 | 1.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.1 | 5.7 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
1.1 | 7.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.1 | 1.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
1.1 | 6.4 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
1.0 | 3.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
1.0 | 3.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.0 | 5.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.0 | 3.0 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
1.0 | 3.0 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.9 | 3.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.9 | 9.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.9 | 3.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.9 | 2.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.9 | 1.8 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.9 | 3.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.9 | 2.7 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.9 | 2.7 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.9 | 2.7 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.9 | 0.9 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.9 | 2.6 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.9 | 6.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.9 | 3.5 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.9 | 0.9 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.8 | 5.9 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.8 | 2.5 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.8 | 5.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.8 | 2.5 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.8 | 4.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.8 | 2.5 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.8 | 4.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.8 | 4.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.8 | 0.8 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.8 | 8.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.8 | 3.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.8 | 9.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.8 | 2.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.8 | 2.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.8 | 2.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.8 | 0.8 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.8 | 4.5 | GO:0035473 | lipase binding(GO:0035473) |
0.7 | 3.7 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.7 | 2.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.7 | 3.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.7 | 1.5 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.7 | 2.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.7 | 2.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.7 | 2.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.7 | 2.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.7 | 5.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.7 | 0.7 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.7 | 2.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.7 | 3.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.7 | 2.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.7 | 2.8 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.7 | 4.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.7 | 2.8 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.7 | 5.5 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.7 | 4.8 | GO:0046790 | virion binding(GO:0046790) |
0.7 | 2.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.7 | 3.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.7 | 5.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.7 | 0.7 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.7 | 2.0 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.6 | 7.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.6 | 3.8 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.6 | 1.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.6 | 1.9 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.6 | 7.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.6 | 2.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.6 | 1.9 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.6 | 2.5 | GO:0030984 | kininogen binding(GO:0030984) |
0.6 | 0.6 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.6 | 3.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.6 | 2.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.6 | 2.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.6 | 1.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.6 | 2.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.6 | 0.6 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.6 | 4.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.6 | 1.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.6 | 9.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.6 | 3.5 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.6 | 2.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.6 | 2.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.6 | 0.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.6 | 0.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.6 | 1.7 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.6 | 3.4 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.6 | 1.7 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.6 | 0.6 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.6 | 1.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.6 | 2.8 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.6 | 2.8 | GO:0005534 | galactose binding(GO:0005534) |
0.6 | 2.2 | GO:0009374 | biotin binding(GO:0009374) |
0.5 | 0.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.5 | 0.5 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.5 | 1.6 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.5 | 2.7 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.5 | 2.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.5 | 5.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.5 | 4.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.5 | 0.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.5 | 4.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.5 | 3.6 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.5 | 2.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.5 | 7.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.5 | 0.5 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.5 | 1.5 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.5 | 1.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.5 | 1.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.5 | 1.5 | GO:0019961 | interferon binding(GO:0019961) |
0.5 | 1.0 | GO:0070905 | serine binding(GO:0070905) |
0.5 | 1.5 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.5 | 1.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.5 | 3.5 | GO:0008494 | translation activator activity(GO:0008494) |
0.5 | 1.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 1.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.5 | 0.5 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.5 | 3.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.5 | 1.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.5 | 1.9 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.5 | 3.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 3.7 | GO:0031386 | protein tag(GO:0031386) |
0.5 | 1.9 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.5 | 4.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.5 | 2.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.4 | 1.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.4 | 1.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.4 | 5.8 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.4 | 1.3 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 3.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.4 | 2.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.4 | 13.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.4 | 8.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 12.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.4 | 4.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.4 | 0.9 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.4 | 10.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.4 | 4.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.4 | 1.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.4 | 13.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.4 | 1.7 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.4 | 6.0 | GO:0016594 | glycine binding(GO:0016594) |
0.4 | 8.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.4 | 1.7 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.4 | 2.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 2.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.4 | 3.8 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.4 | 1.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.4 | 9.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.4 | 1.3 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.4 | 1.7 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.4 | 0.4 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.4 | 0.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.4 | 1.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.4 | 0.4 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.4 | 0.8 | GO:0030145 | manganese ion binding(GO:0030145) |
0.4 | 1.2 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.4 | 0.4 | GO:0051379 | beta-adrenergic receptor activity(GO:0004939) epinephrine binding(GO:0051379) norepinephrine binding(GO:0051380) |
0.4 | 0.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.4 | 1.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.4 | 1.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.4 | 2.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.4 | 1.6 | GO:0031433 | telethonin binding(GO:0031433) |
0.4 | 0.4 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.4 | 0.8 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.4 | 0.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.4 | 0.4 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.4 | 1.2 | GO:0004359 | glutaminase activity(GO:0004359) |
0.4 | 4.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 12.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.4 | 4.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.4 | 1.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.4 | 0.8 | GO:0034618 | arginine binding(GO:0034618) |
0.4 | 6.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 3.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.4 | 0.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.4 | 1.5 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.4 | 1.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 0.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.4 | 1.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.4 | 1.5 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.4 | 1.9 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.4 | 3.4 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.4 | 1.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.4 | 1.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.4 | 1.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.4 | 1.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 0.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.4 | 0.4 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.4 | 0.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 2.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.4 | 2.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.4 | 0.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 1.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.4 | 4.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.4 | 1.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.4 | 1.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 3.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.4 | 1.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 0.7 | GO:0051425 | PTB domain binding(GO:0051425) |
0.4 | 1.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.4 | 1.8 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.4 | 0.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.4 | 0.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 1.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.4 | 2.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.3 | 0.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.3 | 1.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 2.4 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 2.7 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.3 | 1.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 0.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 1.4 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.3 | 4.1 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 4.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 3.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.3 | 1.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.3 | 1.0 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.3 | 4.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 1.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.3 | 2.3 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.3 | 8.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.3 | 1.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.3 | 0.7 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.3 | 1.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 1.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.3 | 2.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.3 | 4.5 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.3 | 10.6 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.3 | 2.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.3 | 1.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 2.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.3 | 1.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 1.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.3 | 0.6 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.3 | 0.9 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 0.6 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.3 | 4.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.3 | 0.9 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.3 | 0.9 | GO:0043398 | HLH domain binding(GO:0043398) |
0.3 | 1.9 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 2.1 | GO:0043955 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.3 | 0.9 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.3 | 1.5 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.3 | 2.7 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.3 | 1.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 1.2 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.3 | 0.9 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.3 | 4.8 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.3 | 0.3 | GO:0097001 | ceramide binding(GO:0097001) |
0.3 | 0.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 0.9 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 1.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 1.8 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.3 | 1.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 0.9 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 1.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.3 | 1.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 3.4 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.3 | 1.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.3 | 0.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 2.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 1.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.3 | 2.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.3 | 2.0 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 4.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.3 | 0.6 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.3 | 1.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 30.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.3 | 0.8 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.3 | 0.3 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) alpha2-adrenergic receptor activity(GO:0004938) |
0.3 | 0.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.3 | 0.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.3 | 6.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 1.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 3.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 1.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 1.1 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.3 | 0.8 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 4.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 17.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.3 | 0.5 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.3 | 1.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.3 | 0.8 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.3 | 1.9 | GO:0005542 | folic acid binding(GO:0005542) |
0.3 | 0.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.3 | 8.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 0.5 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 0.8 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 2.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.3 | 0.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.3 | 2.9 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.3 | 1.0 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) DNA polymerase activity(GO:0034061) |
0.3 | 2.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 0.3 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.3 | 0.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.3 | 1.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 1.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.3 | 2.3 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 2.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.3 | 3.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 0.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 0.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 1.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 1.5 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 0.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.2 | 0.5 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 0.7 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 0.2 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.2 | 3.2 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.2 | 0.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 2.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 1.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 1.0 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.2 | 1.7 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 0.5 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 0.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 1.9 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 0.2 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 1.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 3.8 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.2 | 2.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.5 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 0.7 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.2 | 1.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 2.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 0.7 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 0.7 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 3.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 1.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 0.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.2 | 0.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 1.4 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.2 | 2.5 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 0.9 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
0.2 | 0.7 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 0.7 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.2 | 1.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 4.0 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 0.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 0.4 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 1.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 1.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 1.1 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 4.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 1.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 2.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 0.6 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.2 | 0.9 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 1.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.2 | 0.4 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) IgG receptor activity(GO:0019770) |
0.2 | 0.6 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 7.1 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 0.4 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 0.9 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 0.9 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.2 | 1.1 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.2 | 2.1 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 1.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 1.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 1.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 5.6 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 0.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 0.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 1.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 1.0 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 1.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 1.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 1.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 0.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 1.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 0.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 3.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 1.6 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.2 | 0.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 0.2 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.2 | 2.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 0.8 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.2 | 0.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 0.6 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 2.9 | GO:0051287 | NAD binding(GO:0051287) |
0.2 | 2.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 0.6 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 0.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 3.4 | GO:0045543 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.2 | 0.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 2.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 1.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 0.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 2.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 28.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 0.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.6 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.2 | 0.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.2 | 0.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 4.8 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 0.6 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 1.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 0.9 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.2 | 0.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 1.8 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.2 | 0.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 0.9 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 0.5 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.2 | 0.5 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.2 | 0.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 0.7 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.2 | 0.7 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 0.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 1.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 0.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 1.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 1.8 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.2 | 0.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 4.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 2.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 1.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 0.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 0.5 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 0.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 0.7 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 0.2 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.2 | 2.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 0.7 | GO:0008238 | exopeptidase activity(GO:0008238) |
0.2 | 0.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 6.3 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.2 | 2.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 0.7 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.2 | 3.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 33.5 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 0.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 8.8 | GO:0000149 | SNARE binding(GO:0000149) |
0.2 | 1.9 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 13.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.2 | 0.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 0.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 0.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 1.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 1.5 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 1.0 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 0.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 3.0 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.2 | 0.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.2 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 0.5 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 1.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 1.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.2 | 1.0 | GO:0015491 | cation:cation antiporter activity(GO:0015491) |
0.2 | 2.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.2 | 0.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 0.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 2.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 1.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 0.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.2 | 1.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 0.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 0.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 0.6 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 0.2 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.2 | 0.3 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 0.6 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 0.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.2 | 0.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 2.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 3.5 | GO:0044105 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.2 | 2.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 2.0 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 7.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 0.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 0.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 1.5 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 0.2 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.2 | 0.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.3 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 0.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.7 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 10.3 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 1.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 1.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 3.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 1.0 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 1.7 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 4.6 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 1.0 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 1.0 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 2.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.7 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 1.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.6 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.6 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.5 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.7 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 7.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 3.1 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 0.8 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.4 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 3.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 1.9 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.8 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 1.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 1.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.1 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.1 | 0.5 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 1.0 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 1.3 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 0.1 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.4 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.6 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.6 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 1.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 1.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 1.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.6 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 7.9 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 1.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 7.2 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.1 | 1.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 2.9 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 4.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 1.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 4.1 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.1 | 1.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 1.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 1.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.3 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 1.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 1.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.3 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 1.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 2.0 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 1.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.3 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 0.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 11.6 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 4.2 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 1.8 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 2.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 0.7 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 1.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.7 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.1 | 0.3 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.1 | 2.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 0.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 1.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 1.6 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 0.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.6 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 0.3 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 1.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 1.5 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.1 | 3.8 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 1.5 | GO:0005186 | pheromone activity(GO:0005186) |
0.1 | 0.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 1.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 1.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.6 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.2 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 2.1 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 0.4 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 2.9 | GO:0005254 | chloride channel activity(GO:0005254) |
0.1 | 0.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.2 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.1 | GO:0089720 | death effector domain binding(GO:0035877) caspase binding(GO:0089720) |
0.1 | 0.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.1 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.1 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 2.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 1.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 1.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 3.4 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 8.7 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 4.2 | GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides(GO:0016818) |
0.1 | 0.3 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 2.7 | GO:0008907 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.8 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 1.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 6.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.1 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.1 | 0.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 1.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 4.9 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.3 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 0.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 2.0 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.5 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 1.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.1 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.3 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.5 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.2 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.5 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.2 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 2.0 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.1 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 0.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.5 | GO:0034778 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 1.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.1 | 19.4 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 1.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 1.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 1.3 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.1 | 1.7 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 4.2 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.1 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.1 | 0.1 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.2 | GO:1901338 | catecholamine binding(GO:1901338) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 3.4 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.4 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 1.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 1.6 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 2.4 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.3 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.0 | 3.3 | GO:0015631 | tubulin binding(GO:0015631) |
0.0 | 1.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.1 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.0 | 0.0 | GO:0032404 | mismatch repair complex binding(GO:0032404) MutSalpha complex binding(GO:0032407) |
0.0 | 0.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.0 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 4.5 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.2 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.0 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.0 | 1.9 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 30.4 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.0 | 0.1 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.0 | 0.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.2 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.0 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 1.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 4.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.9 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.3 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.4 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.2 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 6.3 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.2 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 8.9 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 1.0 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.0 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.0 | 0.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 9.6 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.0 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 0.2 | GO:0022841 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.0 | 0.2 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.0 | 0.3 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.0 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 1.1 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.0 | 0.1 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 2.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.6 | 5.4 | ST STAT3 PATHWAY | STAT3 Pathway |
0.6 | 1.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.6 | 5.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.5 | 12.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.5 | 0.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.5 | 2.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.5 | 2.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.5 | 17.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.5 | 3.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.5 | 8.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.4 | 14.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.4 | 2.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 6.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.4 | 3.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.4 | 10.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.4 | 4.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.4 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 18.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.4 | 0.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 1.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 7.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 1.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.3 | 5.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 4.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 2.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 3.7 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 2.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.3 | 2.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 5.9 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.3 | 7.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 1.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.3 | 6.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.3 | 5.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 5.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 5.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 2.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 11.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.3 | 12.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 2.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 1.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 2.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 11.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 2.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 3.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 3.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 8.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 10.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 0.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 1.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 0.9 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 3.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 3.0 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 2.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 5.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 3.7 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 2.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 0.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 1.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 39.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 1.0 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 0.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 2.5 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 1.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 0.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 1.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 3.1 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 3.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 0.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 3.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 2.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 1.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 0.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 1.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 0.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 1.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 1.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 5.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 0.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 1.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 6.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 1.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 2.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 4.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 2.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 3.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 3.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.7 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.9 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 4.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 1.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 2.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 2.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 14.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 1.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 2.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 1.6 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 1.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.2 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.2 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.2 | PID BMP PATHWAY | BMP receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 27.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.1 | 15.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.1 | 15.8 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.9 | 0.9 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.9 | 13.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.8 | 0.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.7 | 2.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.6 | 6.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.6 | 11.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.6 | 7.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.6 | 5.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.6 | 0.6 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.6 | 3.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.6 | 1.1 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.6 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.6 | 5.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.5 | 2.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.5 | 7.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.5 | 2.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.5 | 4.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.5 | 2.0 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.5 | 1.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.5 | 5.8 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.5 | 4.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.5 | 4.6 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.5 | 4.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.5 | 12.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.4 | 2.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.4 | 4.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.4 | 9.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.4 | 4.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 13.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.4 | 2.4 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.4 | 0.8 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.4 | 2.7 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.4 | 0.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.4 | 3.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 3.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 5.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.4 | 10.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.4 | 0.7 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.4 | 2.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 0.3 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.3 | 4.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.3 | 5.5 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.3 | 2.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.3 | 3.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.3 | 7.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 2.9 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.3 | 6.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 3.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.3 | 7.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.3 | 3.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.3 | 1.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.3 | 1.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.3 | 1.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.3 | 0.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 4.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 4.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.3 | 3.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 7.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.3 | 1.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.3 | 3.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 4.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 8.8 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.3 | 8.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 1.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 1.0 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 1.0 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.3 | 2.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.2 | 10.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 1.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 4.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 1.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 2.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 9.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 3.2 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 1.4 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.2 | 4.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 0.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 5.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 2.9 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.2 | 2.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 0.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 3.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 5.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 0.2 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.2 | 4.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 35.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 2.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 0.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.2 | 3.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 3.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 3.6 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.2 | 3.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 1.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 2.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.2 | 1.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 2.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 0.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 4.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 1.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 1.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 0.2 | REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR | Genes involved in Downstream signaling of activated FGFR |
0.2 | 0.7 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 3.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 2.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 2.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 7.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 0.2 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.2 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 0.8 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 0.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 0.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 6.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 3.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 1.2 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 1.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 1.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 3.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.0 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 1.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 0.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 8.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 5.7 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 3.6 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.1 | 1.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 2.0 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 0.7 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.1 | 1.8 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 5.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.5 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 1.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 0.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 3.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 2.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.7 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.1 | 1.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.0 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 1.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 8.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.8 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 3.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 0.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 0.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 1.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 2.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 2.5 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.4 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 0.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.2 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 0.1 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.1 | 1.5 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 1.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 0.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 2.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 3.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 0.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 1.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.5 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.1 | 0.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 0.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 2.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 2.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.2 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.4 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 0.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.0 | REACTOME DEFENSINS | Genes involved in Defensins |